News

Categories Archives


You are currently viewing all posts published under Science Transfer

Like Sleeping Beauty, some research lies dormant for decades

Why do some discoveries fade into obscurity while others blaze a new trail the moment they are published? More mysteriously, why do some research papers remain dormant for years and then suddenly explode with great impact upon the scientific community? The last group, dubbed “sleeping beauties,” is the subject of a new study from the Indiana University Bloomington School of Informatics and Computing’s Center for Complex Networks and Systems. It…

Read more

Renewing Hope Against Bacteria

Slavia Epstein | Northeastern University A handful of dirt from a field has yielded what may be the first of a new family of antibiotics. Early tests suggest this one has the potential to be especially powerful, providing a new weapon against the growing threat of drug-resistant superbugs. Scientists at Northeastern University in Boston and a small company called NovoBiotic Pharmaceuticals used a new method to find the compound, which…

Read more

New IP handbook from ACRL

ACRL announces the publication of Owning and Using Scholarship: An IP Handbook for Teachers and Researchers by Kevin L. Smith, JD. Copyright and other types of laws regulating intellectual property create an increasing concern for contemporary scholarship. The digital environment has created exciting new opportunities and possibilities for scholars to work and distribute their work. But these new opportunities also create issues that did not arise in the analog world. …

Read more

New book and TV series, ‘How We Got to Now’

We all know how important the printing press has been to human history. Invented in the 1400s, it allowed the mass production of books, newspapers and magazines. That fueled rapid increases in literacy and spawned new industries such as publishing. It also laid the foundation for colossal changes in how citizens expected to be governed, leading to more open and democratic societies. But did you know that the printing press…

Read more

Venture Capitalists Return to Backing Science Start-Ups

Mike Massee/XCOR Aerospace Vestaron makes an eco-friendly pesticide derived from spider venom. Bagaveev uses 3-D printers to make rocket engines for nanosatellites. Transatomic Power is developing a next-generation reactor that runs on nuclear waste. They all have one thing in common: money from Silicon Valley venture capitalists. After years of shying away from science, engineering and clean-technology start-ups, investors are beginning to take an interest in them again, raising hopes…

Read more

NSF awards first grants in new tech transfer program

A “valley of death” is well-known to entrepreneurs–the lull between government funding for research and industry support for prototypes and products. To confront this problem, in 2013 the National Science Foundation (NSF) created a new program called InTrans to extend the life of the most high-impact NSF-funded research and help great ideas transition from lab to practice. Today, in partnership with Intel Corporation, NSF announced the first InTrans award of…

Read more

NIH and NSF launch Innovation Corps curriculum

A new collaboration between the National Science Foundation (NSF) and the National Institutes of Health (NIH) will give NIH-funded researchers training to help them evaluate their scientific discoveries for commercial potential with the aim of accelerating the translation of biomedical innovations into applied health technologies. I-Corps™ at NIH is a pilot of the NSF Innovation Corps™ (I-Corps™) program specially tailored for biomedical research. Academic researchers and entrepreneurs with Small Business…

Read more

Universities seek to boost industry partnerships

Source: MoneyTree Report (PwC, NVCA) When Matthew Shair discovered a protein involved in causing blood cancer — and a small molecule that might disrupt that protein — he saw the makings of a new drug. Facing years of costly work to prove its worth, Shair, a chemist at Harvard University in Cambridge, Massachusetts, did not seek funding from the usual sources, pharmaceutical companies and venture-capital firms. Instead, in 2012, he…

Read more

This is a unique website which will require a more modern browser to work! Please upgrade today!